While many European startups have seen their private valuations tumble, French insurer Alan has pushed in the opposite direction: a fresh funding round lifts its value to about €5 billion (roughly $5.8 billion), signaling renewed investor appetite for health-tech firms that can expand quickly. The move matters now because it highlights how backers are balancing…